The Study

• The Doctors at Clinical Research Associates of Tidewater are enrolling for a clinical trial to test the effectiveness of an investigational medication to treat scalp psoriasis.

Qualified Participants:

• A clinical diagnosis of stable (at least 6 months) scalp psoriasis involving at least 10% of the scalp and clinical signs of psoriasis vulgaris on trunk and or limbs.
• Scalp psoriasis consistent with at least moderate severity at the scalp target lesion site.
• Agree to stop the use of all other topical or systemic antipsoriatic treatments, corticosteroids, immunosuppressive drugs, calcium supplements and Vitamin D supplements or Vitamin D analogs at a dose >400 IU/day during the study.
• Agree to avoid tanning booths, sun lamps and excessive non-prescription UV light exposure (including natural sunlight) during the study.
• Currently in general good health and free from any clinically significant disease, other than scalp psoriasis and psoriasis vulgaris, that may interfere with the study evaluations.

If Qualified and you participate you will receive:

• This study will last for approximately 4 weeks with a total of 3 office visits.
• Compensation for time and travel for participation and completion of a qualified study.

Take the next step, call us at (757) 627-6798 and ask for the Asthma enrollment team, better yet, fill out the brief form below, and we will call you!